Safety, Tolerability, and Pharmacodynamics of AZD3366 (Optimized Human CD39L3 Apyrase) Alone and in Combination With Ticagrelor and Acetylsalicylic Acid: A Phase 1, Randomized, Placebo-Controlled Study.
Dimitris KardassisAnn-Charlotte EgnellMagnus ÅstrandSamuel J DanielsCarl WhatlingOla FjellströmAnders GabrielsenPublished in: Journal of the American Heart Association (2024)
URL: https://www.clinicaltrials.gov; Unique Identifier: NCT04588727.